Literature DB >> 17992021

Quantitative assessment of the degree of ductal steal using celiac artery blood flow to left ventricular output ratio in preterm infants.

Afif El-Khuffash1, Mary Higgins, Kevin Walsh, Eleanor J Molloy.   

Abstract

BACKGROUND: Determining the significance of a patent ductus arteriosus (PDA) remains difficult in preterm neonates and current echocardiographic markers give little information about ductal steal. We hypothesized that the relationship between celiac artery flow (CAF) and left ventricular output (LVO) in the presence of a PDA may determine haemodynamic significance.
OBJECTIVES: To examine CAF to LVO ratio (CAF:LVO) in the presence and the absence of a PDA in preterm neonates, and to compare CAF:LVO to current echocardiographic markers of a significant PDA.
METHODS: This was a prospective observational study of neonates <1,500 g. Echocardiography was performed at 12 h and day 3. PDA, LVO and CAF were measured by echocardiography. The infants were divided into those who developed a significant PDA (PDA >1.4 mm and left atrial to aortic ratio >1.5 on day 3) and controls. A further assessment was carried out following successful PDA treatment with ibuprofen or surgical ligation.
RESULTS: A total of 33 infants were enrolled. 19 infants had a PDA (median gestation 27 weeks, birth weight 915 g), and 14 controls (gestation 28.7 weeks, birth weight 1,110 g). At 12 h, there was no difference in CAF, LVO or CAF:LVO. On day 3, there was a significant difference in CAF:LVO between PDA versus control groups. CAF:LVO significantly correlated with conventional markers of ductal significance. A CAF:LVO value of 0.10 had a sensitivity of 93% and a specificity of 78% for the presence of a significant PDA. Following successful PDA treatment CAF:LVO returned to levels similar to controls.
CONCLUSION: CAF:LVO may be used to determine which PDA warrants treatment and serve as a marker of treatment success. Trials are needed to correlate CAF:LVO with outcome and the impact of basing PDA treatment on this ratio. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17992021     DOI: 10.1159/000110869

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  7 in total

Review 1.  Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?

Authors:  Arvind Sehgal; Patrick J McNamara
Journal:  Eur J Pediatr       Date:  2009-04-22       Impact factor: 3.183

2.  Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.

Authors:  Johannes Buca Letshwiti; Jan Sirc; Ruth O'Kelly; Jan Miletin
Journal:  Eur J Pediatr       Date:  2014-06-05       Impact factor: 3.183

3.  Effects of chest compressions on cardiovascular and cerebral hemodynamics in asphyxiated near-term lambs.

Authors:  Kristina S Sobotka; Graeme R Polglase; Georg M Schmölzer; Peter G Davis; Claus Klingenberg; Stuart B Hooper
Journal:  Pediatr Res       Date:  2015-06-18       Impact factor: 3.756

4.  The methodology of Doppler-derived central blood flow measurements in newborn infants.

Authors:  Koert A de Waal
Journal:  Int J Pediatr       Date:  2012-01-16

5.  Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.

Authors:  Jonathan L Slaughter; Clifford L Cua; Jennifer L Notestine; Brian K Rivera; Laura Marzec; Erinn M Hade; Nathalie L Maitre; Mark A Klebanoff; Megan Ilgenfritz; Vi T Le; Dennis J Lewandowski; Carl H Backes
Journal:  BMC Pediatr       Date:  2019-09-13       Impact factor: 2.125

6.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30

7.  Outcomes of Left Ventricular Function According to Treatment Response for a Patent Ductus Arteriosus in Preterm Infants.

Authors:  Soo Jung Kang; Young Sun Cho; Seo Jung Hwang; Hyo Jin Kim
Journal:  J Cardiovasc Ultrasound       Date:  2017-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.